600380 Stock Overview
Joincare Pharmaceutical Group Industry Co.,Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 600380 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Joincare Pharmaceutical Group Industry Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.89 |
| 52 Week High | CN¥13.25 |
| 52 Week Low | CN¥9.40 |
| Beta | 0.43 |
| 1 Month Change | -5.39% |
| 3 Month Change | -4.05% |
| 1 Year Change | -1.89% |
| 3 Year Change | -6.92% |
| 5 Year Change | 9.67% |
| Change since IPO | 1.32% |
Recent News & Updates
Earnings Working Against Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Share Price
Jan 03
Is Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) A Risky Investment?
Nov 17Recent updates
Earnings Working Against Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Share Price
Jan 03Is Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) A Risky Investment?
Nov 17Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Business And Shares Still Trailing The Market
Aug 13We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease
Jun 23Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being
May 31Joincare Pharmaceutical Group IndustryLtd's (SHSE:600380) Conservative Accounting Might Explain Soft Earnings
Apr 09Investors Don't See Light At End Of Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Tunnel
Mar 04Shareholder Returns
| 600380 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.9% | -1.1% | -0.6% |
| 1Y | -1.9% | 0.5% | 12.6% |
Return vs Industry: 600380 underperformed the CN Pharmaceuticals industry which returned 0.5% over the past year.
Return vs Market: 600380 underperformed the CN Market which returned 12.6% over the past year.
Price Volatility
| 600380 volatility | |
|---|---|
| 600380 Average Weekly Movement | 3.1% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in CN Market | 10.9% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 600380 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600380's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 14,365 | Xiong Yu | www.joincare.com |
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products primarily in China. The company offers chemical preparation for drugs, including digestive tract, cardiovascular and cerebrovascular, antimicrobial, anti-tumor, assisted reproductive, neurological therapeutic, OCT, and other drugs; and traditional Chinese drug preparation production, which includes anti-tumor and cold products.
Joincare Pharmaceutical Group Industry Co.,Ltd. Fundamentals Summary
| 600380 fundamental statistics | |
|---|---|
| Market cap | CN¥20.41b |
| Earnings (TTM) | CN¥1.47b |
| Revenue (TTM) | CN¥15.89b |
13.9x
P/E Ratio1.3x
P/S RatioIs 600380 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600380 income statement (TTM) | |
|---|---|
| Revenue | CN¥15.89b |
| Cost of Revenue | CN¥6.16b |
| Gross Profit | CN¥9.73b |
| Other Expenses | CN¥8.26b |
| Earnings | CN¥1.47b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 08, 2025
| Earnings per share (EPS) | 0.78 |
| Gross Margin | 61.21% |
| Net Profit Margin | 9.25% |
| Debt/Equity Ratio | 22.7% |
How did 600380 perform over the long term?
See historical performance and comparisonDividends
1.7%
Current Dividend Yield23%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/28 19:52 |
| End of Day Share Price | 2025/01/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Joincare Pharmaceutical Group Industry Co.,Ltd. is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yanyin Zhu | China International Capital Corporation Limited |
| Ling Bo Tu | China Minzu Securities |
| Shitong Han | Citic Securities Co., Ltd. |